Articles from Adverse Event Reporting News (April 8, 2008)

Title	Author	Type	Words
Clinical trials investigator accuses drug companies of delaying release of study results.			796
Comparative effectiveness institute to be proposed.			729
FDA announces safety review of J&J's Regranex Gel.			437
FDA cautions use of OTC creams and ointments.		Brief article	180
FDA devises initial list of drugs and biologics for REMS.			409
FDA issues draft guidelines on drug-eluting stents.			596
FDA releases draft 5-year drug safety plan.	Mashaw, Rebecca		1308
FDA reviewing safety of Merck, Mylan drugs.			315
FDA seeks civil penalties from device maker.			349
FDA warns consumers to avoid 'Blue Steel' and 'Hero' dietary supplements.		Brief article	279
Fears grow over Botox safety.		Brief article	271
GSK issues new warning on Relenza.		Brief article	182
Heparin recalled in Europe and Australia as Covidien initiates voluntary recall of syringes in U.S.			565
House panel backs bill to allow FDA to regulate tobacco.	Mashaw, Rebecca	Brief article	289
Lilly settles suit by Alaska over Zyprexa.			479
Notice of Initiation of Disqualification Proceedings and Opportunity to Explain (NIDPOE).	Guy, Matthew		596
Novartis further curbs Zelnorm use.			442
Off-label drug use needs strong oversight, researcher says.			406
Office for Human Research Protections.	Drew, Charles R.; Hopkins, Johns		1358
Office of Research Integrity--finding of scientific misconduct.	Monte, Scott E.	Brief article	213
Overseas drugs hit U.S. regulatory snags.			571
Pfizer denied access to JAMA Files.			442
Risks of OTC drug access may outweigh benefits.			446
St. Jude sued in Canada over defibrillator failures.		Brief article	200
Thalidomide victims seek compensation, 50 years on.			380
TV drug ads should contain FDA phone number: Consumers Union survey.		Report	373
U.K. researcher raises 'red flag' on new drugs.			315
Warning letters.	Klein, Kevin W.		451
Ziagen, Videx under safety review by FDA and EMEA.			522